Showing results (261-270 of 523) with videos related to
Sort By:
Pageof 53
Journal of Clinical Medicine|April 13, 2024
Ergonomic Assessment of Robotic versus Thoracoscopic ThymectomyRiccardo Taje, Michael Peer, Filippo Tommaso Gallina, et al.Annals of Surgical Oncology|January 5, 2019
Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung MetastasectomyUgo Pastorino, Daniele Morelli, Giovanni Leuzzi, et al.Journal of Experimental & Clinical Cancer Research : CR|May 28, 2010
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trialsFotios Loupakis, Emilio Bria, Vanja Vaccaro, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and HopesFilippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.Journal of Clinical Pathology|August 17, 2021
Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option availableCristiana Ercolani, Anna Di Benedetto, Claudia Bonomo, et al.Cancers|June 26, 2026
Functional Recovery as a Survivorship Endpoint in Early-Stage NSCLCGiovanni Leuzzi, Filippo Lococo, Beatrice Cosentino, et al.Critical Reviews in Oncology/Hematology|December 8, 2015
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trialsFrancesco Massari, Alessandra Modena, Chiara Ciccarese, et al.Cancer|October 20, 2011
Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: meta-analytical estimation and implications for therapeutic strategiesFotios Loupakis, Chiara Cremolini, Lisa Salvatore, et al.Mediators of Inflammation|December 13, 2019
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung CancerCarmine Carbone, Geny Piro, Vincenzo Di Noia, et al.Reviews on Recent Clinical Trials|May 20, 2022
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?Filippo Lococo, Marco Chiappetta, Corolina Sassorossi, et al.Pageof 53